Gri bio to present at the h.c. wainwright 26th annual global investment conference

La jolla, ca, sept. 05, 2024 (globe newswire) -- gri bio, inc. (nasdaq: gri) (“gri bio” or the “company”), a biotechnology company advancing an innovative pipeline of natural killer t (nkt) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that marc hertz, phd, chief executive officer will present at the h.c. wainwright 26 th annual global investment conference being held september 9-11, 2024 in new york, ny.
GRI Ratings Summary
GRI Quant Ranking